The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(2,6-dichlorophenyl)-8-methyl-2-(2'-methyl-2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-isoquinoline]-7'-ylamino)pyrido[4,3-d]pyrimidin-5(6H)-one ID: ALA4526423
PubChem CID: 71724880
Max Phase: Preclinical
Molecular Formula: C26H23Cl2N5O
Molecular Weight: 492.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cn(-c2c(Cl)cccc2Cl)c(=O)c2cnc(Nc3ccc4c(c3)CN(C)CC43CC3)nc12
Standard InChI: InChI=1S/C26H23Cl2N5O/c1-15-12-33(23-20(27)4-3-5-21(23)28)24(34)18-11-29-25(31-22(15)18)30-17-6-7-19-16(10-17)13-32(2)14-26(19)8-9-26/h3-7,10-12H,8-9,13-14H2,1-2H3,(H,29,30,31)
Standard InChI Key: UWJHZJSULUUDDG-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 39 0 0 0 0 0 0 0 0999 V2000
16.4305 -20.7104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8432 -21.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2516 -20.7079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2506 -23.0516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9569 -22.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9546 -21.8261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2498 -21.4225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6651 -23.0525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3724 -22.6432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0788 -23.0537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0721 -21.4193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3682 -21.8303 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7852 -21.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7833 -22.6462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2008 -21.8303 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4917 -21.4168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2278 -22.6495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4885 -23.0502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4925 -20.5996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.9026 -21.4117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6115 -21.8128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3128 -21.3948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3016 -20.5768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5832 -20.1786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8848 -20.5989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1690 -20.2045 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.6207 -22.6299 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.5464 -22.6443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5470 -21.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1380 -21.8279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1374 -22.6433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8439 -23.0538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4290 -23.0507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4789 -23.8673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
28 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 29 1 0
5 8 1 0
8 9 1 0
9 10 2 0
10 14 1 0
13 11 1 0
11 12 2 0
12 9 1 0
13 14 2 0
13 16 1 0
14 18 1 0
17 15 1 0
15 16 1 0
17 18 2 0
16 19 2 0
15 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
25 26 1 0
21 27 1 0
28 29 2 0
28 32 1 0
29 2 1 0
2 30 1 0
30 31 1 0
31 32 1 0
31 33 1 0
18 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 492.41Molecular Weight (Monoisotopic): 491.1280AlogP: 5.62#Rotatable Bonds: 3Polar Surface Area: 63.05Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.57CX Basic pKa: 8.17CX LogP: 5.55CX LogD: 4.72Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.40Np Likeness Score: -0.80
References 1. Mastracchio A, Lai C, Torrent M, Bromberg K, Buchanan FG, Ferguson D, Bontcheva V, Johnson EF, Lasko L, Maag D, Shoemaker AR, Penning TD.. (2019) Investigation of biaryl heterocycles as inhibitors of Wee1 kinase., 29 (12): [PMID:31014911 ] [10.1016/j.bmcl.2019.04.017 ]